tm logo

Monitor this mark

View On USPTO

XTESO
Dead/Abandoned
ABANDONED - NO STATEMENT OF USE FILED

no statement of use filed

on 02 Sep 2024

Last Applicant/ Owned by

SLAYBACK PHARMA LIMITED LIABILITY COMPANY

301 Carnegie Center, Suite 303

Princeton

NJ

08540

Serial Number

97760212 filed on 19th Jan 2023

Registration Number

N/A

Correspondent Address

Maureen E. Kelly

Maureen E. Kelly VORYS, SATER, SEYMOUR AND PEASE LLP

Columbus, OH 43216-2255

UNITED STATES

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

XTESO

Hormonal preparation for medicinal use; Pharmaceutical preparations for the treatment of endocrine diseases and disorders; Pharmaceutical preparations for the treatment of hypogonadism

Classification Information

Class [005]
Pharmaceutical Products

Hormonal preparation for medicinal use; Pharmaceutical preparations for the treatment of endocrine diseases and disorders; Pharmaceutical preparations for the treatment of hypogonadism

First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details

Serial Number

No 97760212

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 077549-021

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
02th Sep 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
02th Sep 2024ABANDONMENT - NO USE STATEMENT FILED
30th Jan 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
05th Dec 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05th Dec 2023PUBLISHED FOR OPPOSITION
15th Nov 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
30th Oct 2023APPROVED FOR PUB - PRINCIPAL REGISTER
30th Oct 2023EXAMINER'S AMENDMENT ENTERED
30th Oct 2023EXAMINERS AMENDMENT E-MAILED
30th Oct 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED